Featured
-
Breaking News | Industry News
Stevanato Group Launches After-sales Service Offering
Aims to deliver a more customized experience for optimal machine maintenance, performance and utilization.Kristin Brooks 01.26.21
-
Breaking News | Drug Discovery | Industry News | Preclinical Outsourcing
X-Chem Acquires IntelliSyn and AviSyn
Acquisitions allow the company to offer services for screening, hit validation and lead optimization on existing and new markets.Kristin Brooks 01.26.21
-
Breaking News | Capsules | Cold Chain Management | Fill/Finish | Industry News | Solid Dosage/Semi-solids
Aphena’s $21M Cookeville Expansion Nears Completion
Bottle packaging capacity has been expanded with the installation of 10 high-speed bottling lines to start.Kristin Brooks 01.26.21
-
Breaking News | Collaborations & Alliances
BioMed X, Janssen Enter Oral Drug Delivery Alliance
Aims to discover novel transport mechanisms which could be utilized for oral delivery of therapeutic modalities.Charles Sternberg, Assistant Editor 01.26.21
-
Breaking News | Clinical Trials | Industry News
Care Access Research, AstraZeneca Partner on COVID-19 Antibody Trial
Care Access to provide decentralized, mobile research site operations for AstraZeneca’s AZD7442 Phase III trial in the U.S.Kristin Brooks 01.26.21
-
Breaking News
500+ Sites Join Inato’s Industry Marketplace
Platform aims to make clinical research more inclusive and efficient.Charles Sternberg, Assistant Editor 01.26.21
-
Breaking News | Clinical Trials | Drug Development | Industry News | Laboratory Testing
Caprion-HistoGeneX Rebrands as CellCarta
Recently expanded its scientific capabilities and geographic presence with the acquisitions of Clinical Logistics Inc. and Mosaic Laboratories.Kristin Brooks 01.26.21
-
Breaking News | cGMP Manufacture | Excipients | Industry News
PromoCell Receives EXCiPACT Certification
Manufactures pharmaceutical excipients to GMP standards for tailor-made cell culture media and reagents that fulfill specific regulatory requirements.Kristin Brooks 01.26.21
-
Breaking News | Facilities | Industry News | Injectables | Parenterals
Civica to Build an Essential Medicines Manufacturing Facility in Virginia
Will produce sterile injectable meds used in hospitals for COVID-19 patient care.Tim Wright, Editor, Contract Pharma 01.25.21
-
Bio News | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
Humanigen, Emergent Enter Covid-19 Partnership
Sign contract development and manufacturing agreement for Phase 3 COVID-19 therapeutic candidate lenzilumab.Tim Wright, Editor, Contract Pharma 01.25.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Facilities | Industry News
Samsung Bioepis Opens New Headquarters
The 52,000-square-foot campus to become the hub of Samsung Bioepis’ drive for accelerated development of next-gen biologic medicines.Tim Wright, Editor, Contract Pharma 01.25.21
-
Breaking News | Industry News
Pfizer, BioNTech Enter Vax Pact with COVAX
Initial agreement provides up to 40 million doses of the Pfizer-BioNTech COVID-19 Vaccine to COVAX in 2021, with first deliveries expected in 1Q21.Kristin Brooks 01.22.21
-
Breaking News | Trials & Filings
FDA Approves Janssen’s CABENUVA
Becomes first and only once-monthly, long-acting regimen for the treatment of HIV infection.Kristin Brooks 01.22.21
-
Breaking News | Promotions & Moves
AGC Biologics Appoints Boulder Site GM
David Stewart to oversee the startup, strategic development and operational excellence in large-scale biologics production at the Boulder, CO site.Kristin Brooks 01.22.21
-
Breaking News | Drug Development | Drug Discovery | Industry News
Lilly Completes $1B Acquisition of Prevail
Adds new modality for drug discovery and development and creates a gene therapy program with neuroscience assets.Kristin Brooks 01.22.21
- Civica to Build an Essential Medicines Manufacturing Facility in Virginia
- Humanigen, Emergent Enter Covid-19 Partnership
- Pfizer, BioNTech Enter Vax Pact with COVAX
- Grifols Begins COVID-19 Plasma Treatment Trial
- iosBio Inks Exclusive Vax Platform Pact for COVID-19
- Baxter, Novavax Ink Sterile Manufacturing Agreement
- Fujifilm Diosynth Biotechnologies Begins COVID-19 Vax Production
- AMRI Included in BARDA CDMO Network
- CureVac and Bayer Join Forces
- Botanical Solution Inc. to Supply Pharma Grade QS-21 Vaccine Adjuvant
- Stevanato Group Launches After-sales Service Offering
- X-Chem Acquires IntelliSyn and AviSyn
- Aphena’s $21M Cookeville Expansion Nears Completion
- BioMed X, Janssen Enter Oral Drug Delivery Alliance
- Care Access Research, AstraZeneca Partner on COVID-19 Antibody Trial
- 500+ Sites Join Inato’s Industry Marketplace
- Caprion-HistoGeneX Rebrands as CellCarta
- PromoCell Receives EXCiPACT Certification
- Civica to Build an Essential Medicines Manufacturing Facility in Virginia
- Humanigen, Emergent Enter Covid-19 Partnership
November/December 2020
- Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up
- Ensuring Quality During the Transfer and Scale Up of Rx Drugs
- Inspecting the Unexpected
- Cold Chain Trends
- Catering for the Complex
- Biopharma Contract Manufacturing: Robust Growth Ahead
- DCAT President Talks COVID-19, Drug Manufacturing and Innovation
- The Single-Use Mixing Landscape: Evaluating Your Options
- Self-Medication: Flexibility for Patients and Drug Manufacturers
- Decentralized Trials Fuel AI Revolution in Clinical Research
Contract Service Directory
Search the Directories for A Company:
